Pylote launches Pyclear Protection in US

An innovation that protects patients from the adverse effects of preservatives in pharmaceuticals, cosmetics and food products

Pylote is launching Pyclear Protection in the US

Pylote, a new player in the green mineral chemical sector, is launching Pyclear Protection in the US market.

The French firm says the product, developed from innovative mineral microspheres, was introduced in Europe at Pharmapack 2016, and is a major innovation protecting patients from the adverse effects of preservatives. It is being exhibited at this month's Interphex in New York (2628 April) and at the Arvo Annual Meeting 2016 in Seattle (15 May).

Pyclear Protection collected the Pharmapack Best Exhibitor Innovation Award 2016 for 'Patient Protection & Cost-Efficiency' following its launch at the show.

Pylote says the introduction in the US follows an injection of 2m of capital in January which sets the firm on a new phase in its international sales and marketing development. It will also contribute to accelerating the industrial partnerships being put in place, the firm says.

Schematic of the manufacturing process

Pyclear Protection is said to be a breakthrough innovation that replaces antimicrobial preservatives (i.e. parabens) used in many pharmaceuticals or in cosmetic and food products and for which no change is needed in packaging nor in existing manufacturing processes. The firm says it provides an 'eco-friendly' answer to the regulatory requirements to remove the use of preservatives in products. It is suitable for multi-dose eye drop flasks, catheters and nasal used preparations.

The product safeguards patients from the risk of external contamination and from the adverse effects of preservatives used in drug products and throughout the treatment period and ensures clean and pure doses on each application.

In addition, medical and cosmetic devices using Pylote technology have the advantage of removing through direct contact the risk of contamination of the nozzle tips, due to unintentional contact with skin and/or lacrimal fluid.

Companies